|
1
|
Chow WH and Devesa SS: Contemporary
epidemiology of renal cell cancer. Cancer J. 14:288–301. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Rydzanicz M, Wrzesiński T, Bluyssen HA and
Wesoly J: Genomics and epigenomics of clear cell renal cell
carcinoma: Recent developments and potential applications. Cancer
Lett. 341:111–126. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Thillai K, Allan S, Powles T, Rudman S and
Chowdhury S: Neoadjuvant and adjuvant treatment of renal cell
carcinoma. Expert Rev Anticancer Ther. 12:765–776. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Liu Y, Zhou Y, Feng X, An P, Quan X, Wang
H, Ye S, Yu C, He Y and Luo H: MicroRNA-126 functions as a tumor
suppressor in colorectal cancer cells by targeting CXCR4 via the
AKT and ERK1/2 signaling pathways. Int J Oncol. 44:203–210.
2014.
|
|
5
|
Jiang L, He A, Zhang Q and Tao C: MiR-126
inhibits cell growth, invasion and migration of osteosarcoma cells
by downregulating ADAM-9. Tumour Biol. 35:12645–12654. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sun X, Liu Z, Yang Z, Xiao L, Wang F, He
Y, Su P, Wang J and Jing B: Association of microRNA-126 expression
with clini-copathological features and the risk of biochemical
recurrence in prostate cancer patients undergoing radical
prostatectomy. Diagnostic Pathol. 8:2082013. View Article : Google Scholar
|
|
7
|
Otsubo T, Akiyama Y, Hashimoto Y, Shimada
S, Goto K and Yuasa Y: MicroRNA-126 inhibits SOX2 expression and
contributes to gastric carcinogenesis. PloS One. 6:e166172011.
View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Khella HW, White NM, Faragalla H, Gabril
M, Boazak M, Dorian D, Khalil B, Antonios H, Bao TT, Pasic MD, et
al: Exploring the role of miRNAs in renal cell carcinoma
progression and metastasis through bioinformatic and experimental
analyses. Tumour Biol. 33:131–140. 2012. View Article : Google Scholar
|
|
9
|
Vergho D, Kneitz S, Rosenwald A, Scherer
C, Spahn M, Burger M, Riedmiller H and Kneitz B: Combination of
expression levels of miR-21 and miR-126 is associated with
cancer-specific survival in clear-cell renal cell carcinoma. BMC
Cancer. 14:252014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Zhang GM, Bao CY, Wan FN, Cao DL, Qin XJ,
Zhang HL, Zhu Y, Dai B, Shi GH and Ye DW: MicroRNA-302a suppresses
tumor cell proliferation by inhibiting AKT in prostate cancer. PloS
One. 10:e01244102015. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Qin X, Zhang H, Ye D, Dai B, Zhu Y and Shi
G: B7-H3 is a new cancer-specific endothelial marker in clear cell
renal cell carcinoma. OncoTargets. 6:1667–1673. 2013. View Article : Google Scholar
|
|
12
|
Liu X, Choy E, Hornicek FJ, Yang S, Yang
C, Harmon D, Mankin H and Duan Z: ROCK1 as a potential therapeutic
target in osteosarcoma. J Orthop Res. 29:1259–1266. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu B, Peng XC, Zheng XL, Wang J and Qin
YW: MiR-126 restoration down-regulate VEGF and inhibit the growth
of lung cancer cell lines in vitro and in vivo. Lung Cancer.
66:169–175. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Li X, Wang F and Qi Y: MiR-126 inhibits
the invasion of gastric cancer cell in part by targeting Crk. Eur
Rev Med Pharmacol Sci. 18:2031–2037. 2014.PubMed/NCBI
|
|
15
|
Kim MK, Jung SB, Kim JS, Roh MS, Lee JH,
Lee EH and Lee HW: Expression of microRNA miR-126 and miR-200c is
associated with prognosis in patients with non-small cell lung
cancer. Virchows Arch. 465:463–471. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Guo C, Sah JF, Beard L, Willson JK,
Markowitz SD and Guda K: The noncoding RNA, miR-126, suppresses the
growth of neoplastic cells by targeting phosphatidylinositol
3-kinase signaling and is frequently lost in colon cancers. Genes
Chromosomes Cancer. 47:939–946. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Miko E, Margitai Z, Czimmerer Z, Várkonyi
I, Dezso B, Lányi A, Bacsó Z and Scholtz B: MiR-126 inhibits
proliferation of small cell lung cancer cells by targeting SLC7A5.
FEBS Lett. 585:1191–1196. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhou W, Yin H, Wang T, Liu T, Li Z, Yan W,
Song D, Chen H, Chen J, Xu W, et al: MiR-126-5p regulates
osteolysis formation and stromal cell proliferation in giant cell
tumor through inhibition of PTHrP. Bone. 66:267–276. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Zhang Y, Yang P, Sun T, Li D, Xu X, Rui Y,
Li C, Chong M, Ibrahim T, Mercatali L, et al: MiR-126 and miR-126*
repress recruitment of mesenchymal stem cells and inflammatory
monocytes to inhibit breast cancer metastasis. Nature Cell Biol.
15:284–294. 2013. View
Article : Google Scholar
|
|
20
|
Hamada S, Satoh K, Fujibuchi W, Hirota M,
Kanno A, Unno J, Masamune A, Kikuta K, Kume K and Shimosegawa T:
MiR-126 acts as a tumor suppressor in pancreatic cancer cells via
the regulation of ADAM9. Mol Cancer Res. 10:3–10. 2012. View Article : Google Scholar
|
|
21
|
Taverna S, Amodeo V, Saieva L, Russo A,
Giallombardo M, De Leo G and Alessandro R: Exosomal shuttling of
miR-126 in endothelial cells modulates adhesive and migratory
abilities of chronic myelogenous leukemia cells. Mol Cancer.
13:1692014. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Lu J, Sun M, Mi S, Zhang H, Luo RT,
Chen P, Wang Y, Yan M, Qian Z, et al: Distinct microRNA expression
profiles in acute myeloid leukemia with common translocations. Proc
Natl Acad Sci USA. 105:15535–15540. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Bartel DP: MicroRNAs: Genomics,
biogenesis, mechanism and function. Cell. 116:281–297. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Ambros V: The functions of animal
microRNAs. Nature. 431:350–355. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Pinner S and Sahai E: PDK1 regulates
cancer cell motility by antagonising inhibition of ROCK1 by RhoE.
Nat Cell Biol. 10:127–137. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
26
|
Narumiya S, Tanji M and Ishizaki T: Rho
signaling, ROCK and mDia1, in transformation, metastasis and
invasion. Cancer Metastasis Rev. 28:65–76. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Lin MT, Lin BR, Chang CC, Chu CY, Su HJ,
Chen ST, Jeng YM and Kuo ML: IL-6 induces AGS gastric cancer cell
invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
Int J Cancer. 120:2600–2608. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Schofield AV and Bernard O: Rho-associated
coiled-coil kinase (ROCK) signaling and disease. Crit Rev Biochem
Mol Biol. 48:301–316. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sari I, Berberoglu B, Ozkara E, Oztuzcu S,
Camci C and Demiryurek AT: Role of rho-kinase gene polymorphisms
and protein expressions in colorectal cancer development.
Pathobiology. 80:138–145. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Bu Q, Tang HM, Tan J, Hu X and Wang DW:
Expression of RhoC and ROCK-1 and their effects on MAPK and Akt
proteins in prostate carcinoma. Zhonghua Zhong Liu Za Zhi.
33:202–206. 2011.In Chinese. PubMed/NCBI
|
|
31
|
Shi J, Zhang YW, Yang Y, Zhang L and Wei
L: ROCK1 plays an essential role in the transition from cardiac
hypertrophy to failure in mice. J Mol Cell Cardiol. 49:819–828.
2010. View Article : Google Scholar : PubMed/NCBI
|
